A detailed history of Maryland Capital Advisors Inc. transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Maryland Capital Advisors Inc. holds 35 shares of PMCB stock, worth $62. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Holding current value
$62
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$1.47 - $2.18 $51 - $76
35 New
35 $0

Others Institutions Holding PMCB

About PharmaCyte Biotech, Inc.


  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $37.1M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Maryland Capital Advisors Inc. Portfolio

Follow Maryland Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Advisors Inc. with notifications on news.